Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.



Published on

The Indian Pharmaceutical sector has been on a roll ever since the global economy picked itself up post the 2007 mayhem. Given the strong fundamentals of the Indian Pharmaceutical industry and the global opportunity due to the patent cliff in the western world, listed pharmaceutical stocks have responded well and rallied substantially. While the international opportunities have been good for the bottom line, pharmaceutical stocks with a larger or significant share of the domestic pharma market have come in for a rude shock as the implementation of the new pricing policy outline of the NPPA can sharply erode profitability. As the policy elements are still not clear, it would be premature to judge how individual companies would be affected.

With a view to having a mid journey outlook on expected price performance of pharmaceutical stocks, we decided to conduct a study of the major pharmaceutical stocks using technical analysis and analyse which stocks offer the best opportunity both from a long and short point of view. The exhaustive analysis was done on 29 of the major stocks, the details of which one can obtained from the slideshow.

The analysis was done using weekly chart data to get a more longer term picture and some of the results we found were quite contrary to general market expectation; yet others were quite revealing of exciting investment opportunities. We could have easily summed up our analysis and provided an instant listing of our analysis and recommendations for the benefit of our blog readers, but we thought it more appropriate that the reader “visualize” our analysis as “one picture is worth more than a thousand words.”

Technical analysis is a great science for stock price forecasting, but the overall investment decision can be more solid if backed by hard core fundamental study. In part 2 of the Indian Pharmaceutical Outlook, we would be providing extremely high quality fundamental evaluation on the fortunes of these very 29 stocks so that our faithful blog readers can make investment decisions based on comprehensive analysis.

As with all the content on this blog, the report will be provided FREE. However in order to make a point of the exclusivity of the content, we request blog readers to send us an email so that we could deliver it directly in your email inbox. This we request so that we could obtain your feedback on the same report so that we can improve on the content. We would also like to solicit your opinion on the type of content that readers find interesting so that future blog posts could be based more on reader interest rather than just what we think you should read.

Published in: Economy & Finance
  • Login to see the comments


  1. 1. About Winning Trades Winning Trades ( offers a unique proposition of identifying high yield financial investment /trading ideas with an emphasis on minimizing risk WT is owned and run by Vinit Bolinjkar who has over 16 years of experience in financial markets To get in touch: Email: Phone: +91-9730836363 Other individual experts also contribute content to WT.
  2. 2.  Pharma stocks have had a dream run and outperformed the markets by a wide margin since the beginning of this decade. With the patent cliff playing out globally they are expected to continue to do well throughout the decade. This slide show identifies opportune times to buy individual pharma stocks using technical analysis.
  3. 3. Stocks discussed in this slideshowAjanta Pharma Ltd Glaxosmithkline Pfizer Ltd Pharmaceuticals LtdAlembic Pharmaceuticals Ltd Ranbaxy Laboratories Ltd Glenmark Pharmaceuticals Ltd RPG Life Sciences LtdAurobindo Pharma Ltd IPCA Laboratories Ltd Shasun Pharmaceuticals LtdBiocon Ltd Jubilant Life sciences Ltd Strides Arcolab LtdCadila Healthcare Ltd Lupin Ltd Sun PharmaceuticalCipla Ltd Merck Ltd Industries LtdDishman Pharmaceuticals andChemicals Ltd Natco Pharma Ltd Torrent Pharmaceuticals LtdDivi’s Laboratories Ltd Orchid Chemicals & Unichem Laboratories Ltd Pharmaceuticals LtdDr Reddy’s Laboratories Ltd Vivimed Labs Ltd Panacea Biotec LtdElder Pharmaceuticals Ltd Wockhardt Ltd Wyeth Ltd
  4. 4. Ajanta Pharma Ltd
  5. 5. Alembic Pharmaceuticals Ltd
  6. 6. Aurobindo Pharma Ltd
  7. 7. Biocon Ltd
  8. 8. Cadila Healthcare Ltd
  9. 9. Cipla Ltd
  10. 10. Dishman Pharmaceuticals Chemicals Ltd
  11. 11. Divi’s Laboratories Ltd
  12. 12. Dr Reddy’s Laboratories Ltd
  13. 13. Elder Pharmaceuticals Ltd
  14. 14. Glaxosmithkline Pharmaceuticals Ltd
  15. 15. Glenmark Pharmaceuticals Ltd
  16. 16. IPCA Laboratories Ltd
  17. 17. Jubilant Life Sciences Ltd
  18. 18. Lupin Ltd
  19. 19. Merck Ltd
  20. 20. Natco Pharma Ltd
  21. 21. Orchid Chemicals & Pharmaceuticals Ltd
  22. 22. Panacea Biotec Ltd
  23. 23. Pfizer Ltd
  24. 24. Ranbaxy Laboratories Ltd
  25. 25. RPG Life Sciences Ltd
  26. 26. Shasun Pharmaceuticals Ltd
  27. 27. Strides Arcolab Ltd
  28. 28. Sun Pharmaceutical Industries Ltd
  29. 29. Torrent Pharmaceuticals Ltd
  30. 30. Unichem Laboratories Ltd
  31. 31. Vivimed Labs Ltd
  32. 32. Wockhardt Ltd
  33. 33. Wyeth Ltd
  34. 34. For a FREE Copy of theIndian Pharma Sector: Fundamental Outlook Send us an email at:
  35. 35. Disclaimer:The views expressed in this article are entirely my own and do not reflect theviews of my employer. This report is neither an offer nor a solicitation to purchaseor sell securities. The information and views expressed herein are believed to bereliable, but no responsibility (or liability) is accepted for errors of fact or opinion.Writers and contributors may be trading in or have positions in the securitiesmentioned in their articles. Neither or myself acceptsany liability arising out of the above information / articles.